Document is current
Any future updates will be listed below
-
Authors
Fecarotta, Simona
Vaccaro, Lorenzo
Verde, Alessandra
Alagia, Marianna
Rossi, Alessandro
Colantuono, Chiara
Cacciapuoti, Maria Teresa
Annunziata, Patrizia
Riccardo, Sara
Grimaldi, Antonio
Fusco, Tonya
De Santis, Rosa
Barretta, Fernando
Albano, Lucia
Crisci, Daniela
Vallone, Fabiana
Tarallo, Antonietta
Cesana, Marcella
Brunetti-Pierri, Nicola
Frisso, Giulia
Ruoppolo, Margherita
Cacchiarelli, Davide https://orcid.org/0000-0002-9621-6716
Parenti, Giancarlo
-
Funding
Funding for this research was provided by:
Fondazione Telethon
Giovanni Armenise-Harvard Foundation
Ministero della Salute (Piano Operativo Salute Traiettoria 3, T3-AN-09, “Genomed”, Ricerca Finalizzata 2021, “genOMICA”, MCNT2 2023, “EUCARDIS”)
Ministero dell'Università e della Ricerca (MUR-PRIN-2022, Project PNC 0000001 D3 4 Health, MUR-PRIN-2022)
- License Information
-
More Information
Article History
Received: 17 June 2024
Accepted: 5 January 2025
First Online: 24 January 2025
Declarations
:
: NBS for both biochemistry and genetics was performed according the Italian national law 167/2016 [] Ethics approval from the local ethical committee (Campania 3) was also obtained: GENOMED study (nr. 3/2023). The research conformed to the principle of the Helsinki Declaration.
: Not applicable.
: Davide Cacchiarelli is the founder, shareholder, and consultant of NEGEDIA Srl. Sara Riccardo, Patrizia Annunziata, and Chiara Colantuono are employees of NEGEDIA Srl. The other authors declare that they have no competing interests.
